Your browser doesn't support javascript.
loading
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.
Sandberg, John Tyler; Varnaite, Renata; Christ, Wanda; Chen, Puran; Muvva, Jagadeeswara R; Maleki, Kimia T; García, Marina; Dzidic, Majda; Folkesson, Elin; Skagerberg, Magdalena; Ahlén, Gustaf; Frelin, Lars; Sällberg, Matti; Eriksson, Lars I; Rooyackers, Olav; Sönnerborg, Anders; Buggert, Marcus; Björkström, Niklas K; Aleman, Soo; Strålin, Kristoffer; Klingström, Jonas; Ljunggren, Hans-Gustaf; Blom, Kim; Gredmark-Russ, Sara.
Afiliación
  • Sandberg JT; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • Varnaite R; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • Christ W; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • Chen P; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • Muvva JR; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • Maleki KT; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • García M; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • Dzidic M; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • Folkesson E; Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden.
  • Skagerberg M; Department of Medicine Solna, Division of Infectious Diseases Karolinska Institutet Stockholm Sweden.
  • Ahlén G; Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden.
  • Frelin L; Division of Infectious Diseases and Dermatology Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden.
  • Sällberg M; Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden.
  • Eriksson LI; Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden.
  • Rooyackers O; Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden.
  • Sönnerborg A; Function Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden.
  • Buggert M; Department of Physiology and Pharmacology Karolinska Institutet Stockholm Sweden.
  • Björkström NK; Function Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden.
  • Aleman S; Department of Clinical Science, Technology and Intervention, Division of Anesthesiology and Intensive Care Karolinska Institutet Stockholm Sweden.
  • Strålin K; Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden.
  • Klingström J; Division of Infectious Diseases and Dermatology Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden.
  • Ljunggren HG; Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden.
  • Blom K; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
  • Gredmark-Russ S; Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
Clin Transl Immunology ; 10(7): e1306, 2021.
Article en En | MEDLINE | ID: mdl-34257967
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Clin Transl Immunology Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Clin Transl Immunology Año: 2021 Tipo del documento: Article